Key Metrics of Bristol-Myers Squibb
Revenue$45.0B▼ 2.5% YoYFY 2023
Operating income—
Net profit$8.0B▲ 26.8% YoY
Shareholders' equity$29.4B
Market cap$129BBMY · $63.00
Competitors10identified
About Bristol-Myers Squibb
Sectors
Company details
- Website
- bms.com
- Registered office
- One International Center, 6th Floor, Tower 1 Senapati Bapat Marg, Elphinstone (w), Mumbai, In-mh, 400013
- Listed
- NYSE: BMY
Operational Areas of Bristol-Myers Squibb
Pharmaceuticals & Healthcare›Formulations & Contract Manufacturing
Company summary
Entity details
CINU24230MH2004FTC147232
LEI code3358006K289PUST68466
State codeMH
PIN code400013
Current legal nameBRISTOL-MYERS SQUIBB
Classification—
Listing statusUnlisted
Registration no.147232
Company age—
PAN—
CountryUnited States
CityMumbai
StateMaharashtra
Current statusActive
Date of incorporation—
Registrar of companies—
Authorised capital—
Paid-up capital—
Employee count—
Compliance
Last AGM date—
Last balance sheet—
Next filing dueAOC-4 for FY 2025-26 · 30 Oct 2026
Industry classification
NIC code24230
Description of main activityManufacture of chemicals and chemical products (incl. pharmaceuticals)
Description of business activityManufacture of chemicals and chemical products (incl. pharmaceuticals)
SectorPharmaceuticals & Healthcare · Formulations & Contract Manufacturing
US market & SEC filings
BMY · NYSE · SEC CIK 0000014272
Last price · 23 Oct 2026
$63.00
+3.08%
Market cap$129B
P/E16.3On FY 2023 diluted EPS
Volume15,169,250
SectorHealth CareBiotechnology: Pharmaceutical Preparations
Country · IPOUnited States
BMY share price
Premium
Annual results (SEC EDGAR)
Revenue, operating income, net income, EPS, cash flow, assets, liabilities, equity and debt for every year filed with the SEC are part of the premium plan.
Sign in to continue See plans & pricingFiling compliance
AGM for FY 2025-2630 Sep 2026
Statutory due date passed
AOC-4 for FY 2025-2630 Oct 2026
Statutory due date · 7 days left
MGT-7 for FY 2025-2629 Nov 2026
Statutory due date · 37 days left
Due dates follow the Companies Act: AGM within six months of the year end, AOC-4 within 30 days and MGT-7 within 60 days of the AGM. A filing made but not yet uploaded here shows as pending.
Vendor checks & payment capacity
Sign in with access to company financials to review vendor evidence.
Registered office and contact
Registered officeONE INTERNATIONAL CENTER, 6TH FLOOR, TOWER 1 SENAPATI BAPAT MARG, ELPHINSTONE (W), MUMBAI, IN-MH, 400013
GSTIN—
Email—
Websitehttps://www.bms.com
Members / shareholders—
Directors and key people
Directors are read from the MGT-7 annual return and AOC-4 signatories.
Competitors of Bristol-Myers Squibb
Competitors10identified
Locations1most in United States
Top competitors by location
| Company | Description | Domain | Founded | Location |
|---|---|---|---|---|
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | lilly.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | jjmt.com.tw | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | pg.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | merck.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | amgen.com | 1983 | United States | |
| Part of Gilead Sciences. | gilead.com | 1992 | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | abbott.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | pfizer.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | marriott.com.cn | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | hcahealthcare.com | 2011 | United States |
Similar companies
A
AmgenPharmaceuticals & Healthcare
Same segment: Formulations & Contract Manufacturing · Same location: Mumbai
P
PfizerPharmaceuticals & Healthcare
Same segment: Formulations & Contract Manufacturing · Same location: Mumbai
J
Johnson & JohnsonPharmaceuticals & Healthcare
Same segment: Formulations & Contract Manufacturing · Same location: Mumbai
P
Procter & GamblePharmaceuticals & Healthcare
Same segment: Formulations & Contract Manufacturing · Same location: Mumbai
T
Themis Medicare LimitedPharmaceuticals & Healthcare
Same segment: Formulations & Contract Manufacturing
S
Sakar Healthcare LimitedPharmaceuticals & Healthcare
Same segment: Formulations & Contract Manufacturing
I
IOL Chemicals and Pharmaceuticals Ltd. (India)Pharmaceuticals & Healthcare
Same segment: Formulations & Contract Manufacturing
P
Poly Medicure (India)Pharmaceuticals & Healthcare
Same segment: Formulations & Contract Manufacturing
Charges (secured borrowings)
0 registered charges. Lenders, amounts and dates are part of the premium plan.
Statutory auditors
Auditors are read from the AOC-4 auditor's report section.
Group companies
Business activities and related parties
pharmaceutical industry
Filings
No filings on record yet.